Kashaf Waqar and Zainab, A. 2022. The tale and trials of Efgartigimod: a newly FDA approved drug for the treatment of Myasthenia gravis. Journal of the Pakistan Medical Association. 72, 11 (Oct. 2022), 2366–2367. DOI:https://doi.org/10.47391/JPMA.6388.